Please login to the form below
academia
This page shows the latest academia news and features for those working in and with pharma, biotech and healthcare.
Sanofi taps Evotec for new anti-infectives drive
The idea is to set up an Evotec-led initiative at Sanofi’s R&D unit in Lyons, France - open to collaboration with academia, industry, foundations and government agencies - with the
Latest news
-
Hume Brophy launches new life science division
Drawing in ‘experts’from across the medical communications, science, academia, media, pharma and biotech fields, the team will develop and deliver advocacy platforms, strategic communications and market planning programmes.
-
Yale Cancer Center joins BMS’ II-ON
Launched in 2012, the II-ON sees the collaboration of industry and academia driving the further enhancement of immuno-oncology research.
-
New alliance launches to usher digital therapeutics into the mainstream
It's critical that industry, academia, government, and the medical community work together in the next phase of medical adoption.".
-
UCB collaborates with UK's Medical Research Council
This joint initiative with the MRC is a world-leading collaboration between academia and industry with the aim of enhancing the pace of new drug discovery and improving patient outcomes.”.
-
Ashfield Healthcare launches Cirrus Communications
Importantly, our team members will bring both healthcare industry, academia and agency expertise to Cirrus Communications, which provides added benefit and insight for the teams we support.
More from news
Approximately 9 fully matching, plus 151 partially matching documents found.
Latest Intelligence
-
The rise of real-world evidence
Some people envisage an even bigger role for RWE. One idea floated in academia is to replace phase III trials with real-world studies in which typical patients are randomised to
-
Digital health
Medicine works best when it is a collaboration. If something is going to be clinically significant, it needs to be built-in collaboration with practicing clinical expertise, clinical academia, patient advocacy ... Small health technology companies can be
-
Academic-industry collaboration in the era of big data
its role in a much-needed collaborative approach between pharmaceutical industry and academia. ... Industry is very focused on financial goals while academia has been criticised for being less focused on this area.
-
Digital disruption
But Ferguson acknowledges solving a challenge of this magnitude, which the NHS itself has said it struggles with, should be a collective responsibility, involving industry, the NHS, academia and “anyone that
-
Dispensing with the past
Other backgrounds well represented in pharma boards are academia (27%), financial and professional services (19% and 16% respectively) and consumer goods and services (13%).
More from intelligence
Approximately 1 fully matching, plus 20 partially matching documents found.
Latest appointments
-
Professor Carole Longson moves from NICE to the ABPI
experience, expertise and network in both industry and academia will enable the ABPI to work with our partners to further these objectives.”.
-
Orion appoints VP of oncology, R&D
I hope that my long background in the academia will help in the initiation of new research projects between Orion and the academia.
-
Storm Therapeutics strengthens its board
I look forward to working with the board to help guide Storm’s innovative research programmes, adding my experience from drug discovery in academia, pharma and biotech.”.
-
Neon Therapeutics taps Dr Richard Gaynor for R&D leadership role
Dr Gaynor began his career in academia before joining Lilly in 2002 to oversee both oncology drug discovery and early clinical development.
-
Nobel laureate Dr Walter Gilbert joins Amylyx Pharmaceuticals
Over his 40-year career in industry and academia, Dr Gilbert founded several life sciences companies, including Biogen where he was chief executive officer and chairman of the board between 1981
More from appointments
Approximately 1 fully matching, plus 16 partially matching documents found.
Latest from PMHub
-
21st Century Cures Act: a commercial perspective on how the new FDA regulation could revolutionise use of RWE and analytics in healthcare
It brings numerous changes to the US drug development landscape, impacting patients, academia, research institutions, and industry.
-
Big data, privacy and the rise of genomic testing
to scientists in academia and drug development.
-
Synergy Vision MD appointed as trustee of the Cystic Fibrosis Trust
I believe it is a very exciting time right now – CF research is a huge focus for both academia and the pharmaceutical industry.
-
Making careers in medcomms more visible – Synergy Vision launches new recruitment website
Perhaps it’ s because of the relatively small size of our sector compared to other professions in medicine, academia, law, banking, etc.
-
New appointments announced across Research Partnership’s global offices
disease. Having previously worked for Lifescience, Dynamics, Biovid and in academia, Marianne has gained expertise in a wide range of quantitative methods, including segmentation and trade-off methodologies.
More from PMHub
Approximately 0 fully matching, plus 23 partially matching documents found.
Featured jobs
- Senior Account Manager – Med Comms – Kent
-
Salary TBC
- Senior Medical Writer, Medical Communications, Relocate to Cardi...
-
Excellent Salary
- Medical Writer, e-learning/ training, London
-
Excellent Salary
- Editor > Senior Editor – Medical Education – London
-
Very competitive with excellent benefits
-
Scientific Director
-
Great salary and bebefits
- FREELANCE OPPORTUNITIES!!!!! Medical Education - Healthcare Adve...
-
EXCELLENT DAY RATES AVAILABLE
- Project Manager, Medical Communications, Oxford
-
Excellent Salary
-
Senior Programme Executive
-
Salary TBC
- Editor – Medical Education Agency – Bucks
-
Salary TBC
- Senior Account Director, Healthcare Brand Communications, London
-
Excellent Package
- Project Manager, Medical Communications, London
-
Excellent Salary
-
Senior Medical Writer
-
Great salary and benefits
-
Account Manager, Healthcare PR
-
£40, 000 – £42, 000 great benefits and bonuses
- Senior / Principal Regulatory Writer – Home Working - UK or US
-
HIGHLEY COMPETATIVE SALARY, BONUS &BENEFITS
- Principal Medical Writer, Medical Communications, Relocate to Ca...
-
Excellent Salary
- Senior Account Manager / Account Director
-
Great salary and bebefits
- Editorial Team Leader or Scientific Director
-
£50, 000 - £55, 000 benefits
- Group Account Director, Healthcare Brand Communications, London
-
Excellent Package
- Head of Operations/ BUD, Healthcare PR, London – Excellent leade...
-
Excellent Package
Subscribe to our email news alerts
No results were found
- P&G agrees $4.2bn buy of Merck KGaA’s consumer health unit
- Publicis LifeBrands Team win UK young Cannes Lions competition
- Sobi poaches Pfizer’s Fredrick Wetterlundh
- Rigel and Ultragenyx claim approvals for rare drugs
- VCCP Health strengthens client service team
- Is agile working benefiting the employee or the organisation?
PMHub
CAN advertising
Brief us and you’ll soon see we really CAN do it all. We’re different to other agencies. You’ll get expert...
Latest intelligence
- The threat of antimicrobial resistance
- Why this issue is such a fundamental challenge...
- Meet the CEO behind ReNeuron’s cutting-edge stem cell therapies
- Blue Latitude Health speaks to Olav Hellebo, CEO of ReNeuron, to find out about the biotech’s latest innovation in stem cell therapy and to learn his perspective on navigating the...
- Unique forum will unite NHS and industry to drive innovation
- HSJ Life Sciences Forum will explore key NHS challenges and debate future of medicines, by Sarah Eglington, Client Services Director at Wilmington Healthcare...
Quick links
Infographics
